# | Title | Journal | Year | Citations |
---|
1 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Blood | 2016 | 7,429 |
2 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] | Blood | 1994 | 6,150 |
3 | The 2016 revision of the World Health Organization classification of lymphoid neoplasms | Blood | 2016 | 5,965 |
4 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood | 2017 | 4,375 |
5 | International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes | Blood | 1997 | 4,078 |
6 | Human mesenchymal stem cells modulate allogeneic immune cell responses | Blood | 2005 | 4,024 |
7 | Biologic basis for interleukin-1 in disease | Blood | 1996 | 3,893 |
8 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3,864 |
9 | Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | Blood | 2004 | 3,574 |
10 | WHO-EORTC classification for cutaneous lymphomas | Blood | 2005 | 3,529 |
11 | A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis | Blood | 1996 | 2,995 |
12 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Blood | 2010 | 2,963 |
13 | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Blood | 2002 | 2,907 |
14 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines | Blood | 2008 | 2,887 |
15 | Graft-versus-leukemia reactions after bone marrow transplantation | Blood | 1990 | 2,566 |
16 | Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | Blood | 1975 | 2,470 |
17 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes | Blood | 2012 | 2,458 |
18 | The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial | Blood | 1998 | 2,441 |
19 | Leukocyte-endothelial adhesion molecules | Blood | 1994 | 2,428 |
20 | Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Blood | 2005 | 2,427 |
21 | Clinical staging of chronic lymphocytic leukemia | Blood | 1975 | 2,423 |
22 | A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma | Blood | 1997 | 2,384 |
23 | Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia | Blood | 1999 | 2,376 |
24 | Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia | Blood | 1999 | 2,291 |
25 | Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia | Blood | 1988 | 2,265 |
26 | Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group | Blood | 2009 | 2,128 |
27 | Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors | Blood | 2000 | 2,090 |
28 | Current concepts in the diagnosis and management of cytokine release syndrome | Blood | 2014 | 2,080 |
29 | Nomenclature of monocytes and dendritic cells in blood | Blood | 2010 | 2,046 |
30 | Interleukin-1 and interleukin-1 antagonism | Blood | 1991 | 2,044 |
31 | Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments] | Blood | 1995 | 2,025 |
32 | Improved survival in multiple myeloma and the impact of novel therapies | Blood | 2008 | 2,022 |
33 | Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis | Blood | 1994 | 2,012 |
34 | NADPH Oxidase: An Update | Blood | 1999 | 1,986 |
35 | Chemokines | Blood | 1997 | 1,978 |
36 | Adult T-cell leukemia: clinical and hematologic features of 16 cases | Blood | 1977 | 1,940 |
37 | Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments] | Blood | 1995 | 1,911 |
38 | The World Health Organization (WHO) classification of the myeloid neoplasms | Blood | 2002 | 1,899 |
39 | COVID-19 and its implications for thrombosis and anticoagulation | Blood | 2020 | 1,892 |
40 | Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases | Blood | 1998 | 1,878 |
41 | Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene | Blood | 2002 | 1,819 |
42 | Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 | Blood | 1994 | 1,809 |
43 | The biology of interleukin-6 | Blood | 1989 | 1,803 |
44 | International consensus report on the investigation and management of primary immune thrombocytopenia | Blood | 2010 | 1,802 |
45 | Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis | Blood | 1994 | 1,794 |
46 | European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 | Blood | 2013 | 1,743 |
47 | Interleukin-1 in the pathogenesis and treatment of inflammatory diseases | Blood | 2011 | 1,683 |
48 | Development and validation of a predictive model for chemotherapy-associated thrombosis | Blood | 2008 | 1,682 |
49 | HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Blood | 2006 | 1,681 |
50 | The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications | Blood | 2011 | 1,681 |